Aug 24 (Reuters) - The U.S. Food and Drug Administration has cleared Roche and partner Eli Lilly's blood test to help ...

A blood test that measures a single protein in the bloodstream is reshaping how doctors think about Alzheimer’s disease, ...

The U.S. Food and Drug Administration (FDA) has cleared an innovative blood test for marketing. The test's underlying ...

Roche's Elecsys pTau217 blood test for Alzheimer's disease assessment has secured US Food and Drug Administration (FDA) clearance. Developed in collaboration with Eli Lilly, Elecsys pTau217 is ...

Labcorp (LH) said Monday that its blood test that detects Alzheimer's disease is now available after receiving clearance from the US Food and Drug Administration. The company said its Elecsys pTau-217 ...

In a move that could help drastically slow the advancement of Alzheimer's disease (AD), the US Food and Drug Administration ...

DNA changes in certain blood cancers may signal progression to acute myeloid leukemia or myelofibrosis years before routine ...

The new test promises to be “minimally invasive” and can help doctors identify symptoms of Alzheimer’s disease earlier.

The Food and Drug Administration cleared a blood test for identifying Alzheimer’s disease symptoms, which was developed by Roche and Eli Lilly.

Blood test ©Adobe Stock Images. Roche (USOTC:RHHBY) and Eli Lilly (NYSE:LLY) have secured clearance from the U.S. Food and Drug Administration for a blood test designed to help d ...

The FDA has cleared Roche and Eli Lilly’s Elecsys pTau217 blood test to help detect Alzheimer’s disease in adults with ...